specifically examined patients with MASLD cirrhosis and type 2 diabetes, finding that GLP-1 receptor agonist initiation was linked to reduced risk of unfavorable liver outcomes including hepatic decompensation events and mortality from any cause (aHR: 0.78, 95%CI: 0.68-0.90) relative to non-users, suggesting potential benefits even in advanced liver disease populations [58]
PubMed, Tawfik Khattab, Amr Mohamed, et al
Patients should contact a provider if they experience chest pain, shortness of breath, severe swelling, allergic reaction symptoms, sudden vision changes, or significant mood changes
Adding MOTS-C targets mitochondrial function and metabolic efficiency
L-carnitine uptake in differentiating research subjects cultured muscle [PMID: 1958696] Laboratory literature summary: L-carnitine uptake in differentiating research subjects cultured muscle